ARTICLE | Company News
Baylor, UCB deal
February 15, 2016 8:00 AM UTC
UCB and Baylor partnered to discover therapies to treat neurodegenerative diseases. The university uses functional genetics to identify therapeutic targets. UCB did not respond to inquiries, and the u...